TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Aug 31, 2024 | (FY)Feb 29, 2024 | (Q6)Aug 31, 2023 | (FY)Feb 28, 2023 | (Q6)Aug 31, 2022 | (FY)Feb 28, 2022 | (Q6)Aug 31, 2021 | (FY)Feb 28, 2021 | (Q6)Aug 31, 2020 | (FY)Feb 29, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -7.91%13.05B | 6.87%28.93B | 7.25%14.18B | -15.07%27.07B | -15.12%13.22B | -11.48%31.88B | -1.24%15.57B | 6.88%36.01B | -7.01%15.77B | 3.46%33.69B |
Operating income | -7.91%13.05B | 6.87%28.93B | 7.25%14.18B | -15.07%27.07B | -15.12%13.22B | -11.48%31.88B | -1.24%15.57B | 6.88%36.01B | -7.01%15.77B | 3.46%33.69B |
Cost of sales | 1.83%-7.69B | -6.74%-16.85B | -9.02%-7.84B | 12.54%-15.79B | 16.91%-7.19B | 15.36%-18.05B | 6.02%-8.65B | -9.36%-21.33B | 3.60%-9.2B | -2.88%-19.5B |
Operating expenses | 1.83%-7.69B | -6.74%-16.85B | -9.02%-7.84B | 12.54%-15.79B | 16.91%-7.19B | 15.36%-18.05B | 6.02%-8.65B | -9.36%-21.33B | 3.60%-9.2B | -2.88%-19.5B |
Gross profit | -15.43%5.36B | 7.06%12.08B | 5.14%6.34B | -18.37%11.28B | -12.90%6.03B | -5.84%13.82B | 5.45%6.92B | 3.48%14.68B | -11.39%6.57B | 4.26%14.19B |
Selling expenses | 7.01%-3.82B | -3.78%-8.36B | -0.47%-4.11B | 14.69%-8.05B | 9.94%-4.09B | 2.25%-9.44B | -7.96%-4.54B | -0.12%-9.66B | 11.01%-4.21B | -4.29%-9.64B |
Administrative expenses | 10.41%-495M | -1.27%-1.12B | 3.80%-552.5M | 14.84%-1.1B | 9.50%-574.3M | -4.06%-1.29B | -4.70%-634.6M | 12.03%-1.24B | 15.99%-606.1M | -9.25%-1.41B |
Impairment and provision | -220.00%-1.8M | -20.00%1.2M | 0.00%1.5M | -85.29%1.5M | -50.00%1.5M | 139.84%10.2M | 112.35%3M | -34.03%-25.6M | ---24.3M | 43.32%-19.1M |
-Other impairment is provision | -220.00%-1.8M | -20.00%1.2M | 0.00%1.5M | -85.29%1.5M | -50.00%1.5M | 139.84%10.2M | 112.35%3M | -34.03%-25.6M | ---24.3M | 43.32%-19.1M |
Special items of operating profit | 67.10%77.2M | -41.07%175.9M | -78.35%46.2M | -8.80%298.5M | -31.23%213.4M | 41.08%327.3M | 71.34%310.3M | 21.40%232M | 37.41%181.1M | -6.28%191.1M |
Operating profit | -35.05%1.12B | 14.63%2.79B | 9.20%1.73B | -29.13%2.43B | -23.27%1.58B | -14.02%3.43B | 7.91%2.06B | 20.78%3.99B | -8.77%1.91B | 2.04%3.3B |
Financing income | -21.48%46.8M | 15.38%120M | 22.63%59.6M | -8.61%104M | -33.52%48.6M | -19.12%113.8M | -12.77%73.1M | 154.43%140.7M | 1,189.23%83.8M | 176.50%55.3M |
Financing cost | 23.88%-59.3M | 30.68%-147.3M | 30.01%-77.9M | 2.43%-212.5M | -0.45%-111.3M | 22.02%-217.8M | 20.00%-110.8M | -2.65%-279.3M | -17.17%-138.5M | -28.65%-272.1M |
Earning before tax | -35.09%1.11B | 18.81%2.76B | 12.50%1.71B | -30.18%2.32B | -24.94%1.52B | -13.63%3.33B | 9.06%2.02B | 24.78%3.85B | -6.38%1.85B | 1.34%3.09B |
Tax | 36.75%-234.6M | -12.78%-547.9M | 0.40%-370.9M | 44.77%-485.8M | 37.01%-372.4M | 18.61%-879.6M | -8.48%-591.2M | -38.07%-1.08B | -6.95%-545M | 7.43%-782.7M |
After-tax profit from continuing operations | -34.63%873.8M | 20.40%2.21B | 16.70%1.34B | -24.93%1.84B | -19.95%1.15B | -11.68%2.45B | 9.30%1.43B | 20.26%2.77B | -11.00%1.31B | 4.71%2.3B |
Earning after tax | -34.63%873.8M | 20.40%2.21B | 16.70%1.34B | -24.93%1.84B | -19.95%1.15B | -11.68%2.45B | 9.30%1.43B | 20.26%2.77B | -11.00%1.31B | 4.71%2.3B |
Minority profit | ---- | ---1.7M | ---500K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -34.65%873.8M | 20.49%2.21B | 16.75%1.34B | -24.93%1.84B | -19.95%1.15B | -11.68%2.45B | 9.30%1.43B | 20.26%2.77B | -11.00%1.31B | 4.71%2.3B |
Basic earnings per share | -34.65%0.1409 | 20.49%0.3569 | 16.73%0.2156 | -24.92%0.2962 | -19.94%0.1847 | -11.69%0.3945 | 9.28%0.2307 | 9.27%0.4467 | -24.36%0.2111 | -100.00%0.4088 |
Diluted earnings per share | -34.65%0.1409 | 20.49%0.3569 | 16.73%0.2156 | -24.92%0.2962 | -19.94%0.1847 | -11.69%0.3945 | 9.28%0.2307 | 9.27%0.4467 | -24.36%0.2111 | -100.00%0.4088 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.